Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Enveric Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 18 | 24 | +6 |
| Shares | 1.15M | 2.24M | +1.09M (+95.3%) |
| Value | $2.72M | $4.64M | +$1.92M (+70.7%) |
New holders (9)
Institutions that held Enveric Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 492,553 | $1.02M | 0.00% |
| Scotia Capital Inc. | 94,395 | $195.0K | 0.00% |
| Price T Rowe Associates Inc | 53,100 | $110.0K | 0.00% |
| Integrated Wealth Concepts LLC | 44,441 | $92.0K | 0.00% |
| Two Sigma Investments, LP | 43,800 | $91.0K | 0.00% |
| AdvisorShares Investments LLC | 35,754 | $74.0K | 0.01% |
| Vident Investment Advisory, LLC | 25,152 | $52.0K | 0.00% |
| Squarepoint Ops LLC | 13,273 | $27.0K | 0.00% |
| Cutler Group LP | 6,000 | $12.0K | 0.00% |
Sold out (3)
Institutions that held Enveric Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Penserra Capital Management LLC | 26,986 | $52.0K |
| Signaturefd, LLC | 7,000 | $17.0K |
| FMR LLC | 1 | $0 |